|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||0.660 - 0.660|
|52 Week Range||0.620 - 0.910|
|Beta (3Y Monthly)||0.49|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
A look at the shareholders of Changmao Biochemical Engineering Company Limited (HKG:954) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually Read More...
For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...
March 16 (Reuters) - Changmao Biochemical Engineering Co Ltd : * FY REVENUE RMB630.8 MILLION VERSUS RMB594.4 MILLION * FY PROFIT FOR YEAR ATTRIBUTABLE TO EQUITY HOLDERS OF COMPANY RMB3.4 MILLION VERSUS ...
Feb 9 (Reuters) - Changmao Biochemical Engineering Co Ltd : * SEES ESTIMATED INCREASE IN GROUP'S REVENUE FOR FY * SEES SIGNIFICANT DECLINE IN CONSOLIDATED FY NET PROFITS * EXPECTED RESULT DUE TO SIGNIFICANT ...